UnitedHealth Group Incorporated (UNH) Stock

About UnitedHealth Group Incorporated

UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.

UnitedHealth Group Incorporated is led by CEO Stephen J. Hemsley, employs 400,000 people, headquartered in Eden Prairie, US, publicly traded since 1984.

UnitedHealth Group Incorporated (UNH) stock trades at $407.08 with a market capitalization of $369.69B. The stock is valued at a price-to-earnings (P/E) ratio of 32.12, price-to-book of 3.73, price-to-sales of 0.86. Over the past 52 weeks the stock has ranged between $234.60 and $454.90, and currently trades 10.5% below its 52-week high. It pays a dividend yielding 2.18%.

On profitability, UnitedHealth Group Incorporated generates a return on equity (ROE) of 12.40%, above the typical market average, return on capital employed of 9.49%, an operating margin of 4.19%, a net profit margin of 2.68%.

In its most recent fiscal year, UnitedHealth Group Incorporated reported annual revenue of $447.6B, net profit of $12.1B, revenue has compounded at 11.7% a year over the last five years, profit at -4.8% a year.

The balance sheet shows a debt-to-equity ratio of 0.75, a current ratio of 0.80, total assets of $309.6B, $24.4B in cash and equivalents.

UNH has an average daily trading volume of 6,700,720 shares, a beta of 0.63 (less volatile than the overall market).

Official website: www.unitedhealthgroup.com